The FDA granted accelerated approval to Forzinity (elamipretide), the first treatment for Barth syndrome. Explore how it works and what it signals for mitochondrial health.

Learn how MOTS-c, a mitochondrial peptide, supports metabolism, fat utilization, and exercise resilience. Discover research findings and its role in longevity.